Former U.S. President Joe Biden, aged 82, has been diagnosed with stage 4 prostate cancer that has metastasized to his bones. The diagnosis, confirmed by his office on May 18, 2025, follows a routine physical examination on May 16, prompted by urinary symptoms and the discovery of a prostate nodule. A biopsy confirmed prostate adenocarcinoma with a Gleason score of 9 (Grade Group 5), indicating an aggressive form of cancer.
Biden’s last known prostate-specific antigen (PSA) test was in 2014, and he had not been previously diagnosed with prostate cancer. This revelation has sparked political debate, with critics questioning the transparency of his health disclosures. Former President Donald Trump expressed surprise over the timing of the diagnosis, suggesting that the public had not been informed earlier.
Medical experts have weighed in on the situation. Dr. Adam Weiner, an urologic surgeon at Cedars-Sinai Medical Center, stated that it is entirely reasonable for a person of Biden’s age to present with a new diagnosis of prostate cancer that is metastatic. He noted that screening is generally not recommended for men over 70 due to the quality of life issues that can result from unnecessary treatment.
Nick James, an expert in prostate cancer at The Institute of Cancer Research in London, described the Biden camp’s account of the diagnosis as “plausible even if a bit unusual,” explaining that certain cancers with low PSA production can be missed in blood tests.
Despite the advanced stage of the cancer, Biden’s condition is hormone-sensitive, which may allow for effective treatment options. He and his family are currently exploring treatment avenues and have expressed gratitude for the public’s support during this challenging time.
